Baader Bank Aktiengesellschaft
BankPosition in SGMOQ — Sangamo Therapeutics, Inc
CIK 1542629
Unterschleissheim, 2M
Position in SGMOQ
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$5,722
-$8,173 QoQ
Shares Held
22,888
+10.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SGMOQ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Baader Bank Aktiengesellschaft holds $22,123,898 across 12 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BNTX |
BioNTech SE
|
119,411 | $11,111,193 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,777 | $5,849,989 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,488 | $927,827 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
1,800 | $669,006 | |
| 5 | EXEL |
Exelixis, Inc.
|
11,000 | $598,510 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
14,068 | $497,866 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
2,000 | $489,540 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
5,900 | $481,263 |
All Filings in SGMOQ
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,722 | 22,888 | Shares | Sole | 2026-05-08 | |
| 2025-09-30 | $13,895 | 20,739 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $9,675 | 17,918 | Shares | Sole | 2025-07-10 | |
| No filing history on record for this holder in this stock. | ||||||